FEOC
OFAC SDNCriticalEntity

TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANY

🇮🇷IranCovered Nation26100

FEOC Flagged

TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANY appears on 1 critical federal list. Equipment, services, or transactions involving this entity likely fail FEOC requirements for IRA tax credits (45X, 48E, 30D).

Critical findings

  • OFAC SDN — Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.

Covered nation: The IRA defines China, Russia, Iran, and North Korea as covered nations. Entities operating from these jurisdictions face heightened FEOC scrutiny independent of specific list designations.

Risk Summary
List severityHighOn 1 critical list
Country riskHighIran (covered nation)
Ownership transparencyHighNot in global LEI registry — opacity flag
Parent exposureMediumNo parent data
Cross-list countLow1 federal list

Relationships at a glance

2 nodes · 1 relationships · open Network tab for full view
Federal list
OFAC SDN
Treasury OFAC
This entity
TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANYCovered
Iran

Federal-list cross-reference

This entity appears on 1 federal list under the name shown above.

OFAC SDNTreasury OFAC

Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.

Listed as: TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANY#26100
Source

Relationship graph

2 nodes · 1 relationships
Federal list
OFAC SDN
Treasury OFAC
This entity
TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANYCovered
Iran

Click any node to open its source. Federal lists at top, primary entity in center, parents and curated profile below.

Also known as

TADBIR TED VA DAROYE KISHTADBIR KISH MEDICAL AND PHARMACEUTICAL CO.

Known addresses

  • Iran
  • Unit A103, 1st Floor, Padena Complex, Iran Blvd, Kish, Iran
  • Unit A301, 1st Floor, Padena Complex, Iran Blvd, Kish, Iran
  • Unit 301, 3rd Floor, Sadaf Tower, Kish, Iran

Sanctions programs / authorities

SDGT

Sanctioning authority notes

Secondary sanctions risk: section 1(b) of Executive Order 13224, as amended by Executive Order 13886; Linked To: GLOBAL VISION GROUP.

Data sources

  • OFAC SDN · Treasury OFACsource
Raw record (for audit / legal review)
{
  "source_list": "OFAC_SDN",
  "source_record_id": "26100",
  "source_url": "https://ofac.treasury.gov/specially-designated-nationals-list-data-formats-data-schemas",
  "citation": "Treasury OFAC SDN entry 26100",
  "entity_name": "TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANY",
  "entity_type": "Entity",
  "country": "Iran",
  "aliases": [
    "TADBIR TED VA DAROYE KISH",
    "TADBIR KISH MEDICAL AND PHARMACEUTICAL CO."
  ],
  "addresses": [
    "Iran",
    "Unit A103, 1st Floor, Padena Complex, Iran Blvd, Kish, Iran",
    "Unit A301, 1st Floor, Padena Complex, Iran Blvd, Kish, Iran",
    "Unit 301, 3rd Floor, Sadaf Tower, Kish, Iran"
  ],
  "programs": [
    "SDGT"
  ],
  "date_added": null,
  "raw_data": {
    "grt": "-0- ",
    "title": "-0- ",
    "ent_num": "26100",
    "program": "SDGT",
    "remarks": "Secondary sanctions risk: section 1(b) of Executive Order 13224, as amended by Executive Order 13886; Linked To: GLOBAL VISION GROUP.",
    "tonnage": "-0- ",
    "sdn_name": "TADBIR KISH MEDICAL AND PHARMACEUTICAL COMPANY",
    "sdn_type": "-0- ",
    "call_sign": "-0- ",
    "vess_flag": "-0- ",
    "vess_type": "-0- ",
    "vess_owner": "-0- "
  }
}

Informational only — not legal advice. Cross-list matching is name-based; verify identity with the source authority before procurement or compliance decisions.